ISR’s New Report Profiles ECG Service Provider Performance

Informing the Drug Development and Commercialization Industry Cary, N.C. – December 13, 2011 – Industry Standard Research (ISR) today announced the release of a new report titled “Cardiac Safety / ECG Market Dynamics and Service Provider Performance” in which 79 pharmaceutical sponsor decision-makers provide their insights and forecasts regarding the ECG market by rating 286 … Continued

Research Profiles Industry’s Post-marketing Safety Conduct and Outsourcing

Cary, N.C. – September 19, 2011 – Industry Standard Research (ISR) today announced the release of an important piece of research, this one profiling the post-marketing safety industry. ISR’s new “Post-marketing Safety Market Overview and Outlook” report provides pharmaceutical companies and service providers with much-needed data on the underserved post-marketing safety marketplace.   Compiled from … Continued

Pharmacists Speak Out on Issue of Patient Adherence and Compliance

Cary, N.C. – September 13, 2011 – Industry Standard Research (ISR) today announced the release of a new report titled “Improving Adherence and Compliance: The Pharmacist’s View” in which 86 US-based retail (non-hospital based) pharmacists provided significant insights on the issues surrounding patient adherence and compliance. “When you talk about adherence and compliance, you must … Continued

New Research Profiles the State of the Phase I Market

Cary, N.C. – August 16, 2011 – Industry Standard Research (ISR) today announced the release of their “2011 Phase I Market Overview and Outlook” report, in which 104 pharmaceutical decision makers responsible for Phase I activities provide valuable insight into market size, growth and decline in the number of studies over the next 3 years, … Continued

Profiles of 18 Domestic Chinese Pharmaceutical Companies Point to Opportunities

Cary, N.C. – June 9, 2011 – Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “Domestic Chinese Pharmaceutical Companies: Competitor, Complementor, or Catalyst” This report profiles 18 of the largest and fastest-growing domestic Chinese pharmaceutical companies by examining their corporate structure, current products, therapeutic areas of focus, … Continued

New Research Projects Remote Clinical Monitoring to Double in the Next 4 Years

Cary, N.C. – February 8, 2011 – Industry Standard Research (ISR) today announced the launch of two new and substantial research reports titled “The Future of Clinical Monitoring” and “Clinical Development Staff Quality and Resourcing Models“. “It seems that every week brings the announcement of another merger or acquisition between biopharma companies or between CROs. … Continued

ISR CUSTOMERS